Share on StockTwits

Varian Medical Systems (NYSE:VAR) CFO Elisha W. Finney unloaded 10,000 shares of the stock on the open market in a transaction dated Monday, June 2nd. The shares were sold at an average price of $82.35, for a total value of $823,500.00. Following the sale, the chief financial officer now directly owns 4,496 shares of the company’s stock, valued at approximately $370,246. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Several analysts have recently commented on the stock. Analysts at Morgan Stanley reiterated an “underweight” rating on shares of Varian Medical Systems in a research note on Wednesday, May 7th. They now have a $76.00 price target on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Varian Medical Systems in a research note on Friday, April 25th. They now have a $83.00 price target on the stock. One research analyst has rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the company. The stock currently has an average rating of “Hold” and an average target price of $83.63.

Varian Medical Systems (NYSE:VAR) traded down 0.27% on Tuesday, hitting $82.11. The stock had a trading volume of 375,860 shares. Varian Medical Systems has a 52-week low of $65.70 and a 52-week high of $86.60. The stock has a 50-day moving average of $81.10 and a 200-day moving average of $80.80. The company has a market cap of $8.535 billion and a P/E ratio of 21.13.

Varian Medical Systems (NYSE:VAR) last released its earnings data on Wednesday, April 23rd. The company reported $1.04 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.03 by $0.01. The company had revenue of $779.00 million for the quarter, compared to the consensus estimate of $772.84 million. During the same quarter last year, the company posted $1.04 earnings per share. Varian Medical Systems’s revenue was up 1.4% compared to the same quarter last year. On average, analysts predict that Varian Medical Systems will post $4.30 earnings per share for the current fiscal year.

Varian Medical Systems, Inc, is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.